Application of “omics” to Prion Biomarker Discovery
Figure 1
Summary of the tissues, cell populations, and bodily fluids that provide a source of discovery for biomarkers of prion infection (a). Schema to illustrate the stage-specific diagnostic and therapeutic windows for biomarker identification for diagnosis, disease progression, and monitoring pharmacological interventions (b).
